| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of termination of DNA-templated transcription | 9.48e-06 | 2 | 64 | 2 | GO:0060566 | |
| GeneOntologyBiologicalProcess | positive regulation of termination of RNA polymerase II transcription | 9.48e-06 | 2 | 64 | 2 | GO:1904595 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 5.66e-05 | 4 | 64 | 2 | GO:1904594 | |
| Domain | GOLGA6L | 1.83e-04 | 6 | 66 | 2 | IPR026737 | |
| Domain | PLAC | 1.09e-03 | 14 | 66 | 2 | PF08686 | |
| Domain | GOLGA2L5 | 1.81e-03 | 18 | 66 | 2 | PF15070 | |
| Domain | Golgin_A | 1.81e-03 | 18 | 66 | 2 | IPR024858 | |
| Domain | PLAC | 2.02e-03 | 19 | 66 | 2 | PS50900 | |
| Domain | PLAC | 2.02e-03 | 19 | 66 | 2 | IPR010909 | |
| Domain | TPR_REGION | 2.77e-03 | 165 | 66 | 4 | PS50293 | |
| Domain | TPR | 2.77e-03 | 165 | 66 | 4 | PS50005 | |
| Domain | ADAM_spacer1 | 2.97e-03 | 23 | 66 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.97e-03 | 23 | 66 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.23e-03 | 24 | 66 | 2 | IPR013273 | |
| Domain | EGF_CA | 3.50e-03 | 86 | 66 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 4.90e-03 | 97 | 66 | 3 | IPR018097 | |
| Domain | EGF_CA | 5.19e-03 | 99 | 66 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.34e-03 | 100 | 66 | 3 | PS00010 | |
| Domain | - | 6.18e-03 | 207 | 66 | 4 | 1.25.40.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.27e-03 | 106 | 66 | 3 | IPR000152 | |
| Domain | Cadherin_tail | 7.56e-03 | 37 | 66 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 7.56e-03 | 37 | 66 | 2 | IPR031904 | |
| Domain | Peptidase_M12B_N | 8.38e-03 | 39 | 66 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 8.38e-03 | 39 | 66 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 8.80e-03 | 40 | 66 | 2 | PS00427 | |
| Domain | Reprolysin | 8.80e-03 | 40 | 66 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 8.80e-03 | 40 | 66 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 8.80e-03 | 40 | 66 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 8.80e-03 | 40 | 66 | 2 | IPR001590 | |
| Domain | EGF_CA | 9.23e-03 | 122 | 66 | 3 | SM00179 | |
| Domain | CYSTEINE_SWITCH | 9.23e-03 | 41 | 66 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 9.23e-03 | 41 | 66 | 2 | IPR001762 | |
| Domain | TPR-like_helical_dom | 9.30e-03 | 233 | 66 | 4 | IPR011990 | |
| Domain | EGF-like_Ca-bd_dom | 9.64e-03 | 124 | 66 | 3 | IPR001881 | |
| Domain | Pept_M10_metallopeptidase | 1.01e-02 | 43 | 66 | 2 | IPR001818 | |
| Domain | Kinesin-like_fam | 1.01e-02 | 43 | 66 | 2 | IPR027640 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27323329 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 33333224 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 20301293 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 20504764 | ||
| Pubmed | 4.97e-05 | 329 | 69 | 6 | 17474147 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KANSL3 TLNRD1 KIF26A PCNX4 ZZEF1 WNK1 FBXO46 TOP3B EML3 RGS16 | 6.25e-05 | 1105 | 69 | 10 | 35748872 |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 11867212 | ||
| Pubmed | 8.71e-05 | 43 | 69 | 3 | 21116278 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 24039173 | ||
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 12154121 | ||
| Pubmed | Implication of geranylgeranyltransferase I in synapse formation. | 1.73e-04 | 10 | 69 | 2 | 14622576 | |
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 11988168 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.11e-04 | 11 | 69 | 2 | 9655502 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 2.53e-04 | 12 | 69 | 2 | 10612399 | |
| Pubmed | 2.97e-04 | 457 | 69 | 6 | 22190034 | ||
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 26147758 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 15640798 | ||
| Pubmed | 4.56e-04 | 75 | 69 | 3 | 20637190 | ||
| Pubmed | 4.57e-04 | 16 | 69 | 2 | 29859889 | ||
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 5.81e-04 | 18 | 69 | 2 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 5.81e-04 | 18 | 69 | 2 | 10662547 | |
| Pubmed | Ascl1 Balances Neuronal versus Ependymal Fate in the Spinal Cord Central Canal. | 6.49e-04 | 19 | 69 | 2 | 31461644 | |
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 25190705 | ||
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 24698270 | ||
| Pubmed | 1.10e-03 | 1049 | 69 | 8 | 27880917 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.11e-03 | 588 | 69 | 6 | 38580884 | |
| Pubmed | 1.35e-03 | 1084 | 69 | 8 | 11544199 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.42e-03 | 28 | 69 | 2 | 15347688 | |
| Pubmed | 1.46e-03 | 418 | 69 | 5 | 34709266 | ||
| Pubmed | 1.69e-03 | 432 | 69 | 5 | 7671812 | ||
| Pubmed | 1.74e-03 | 31 | 69 | 2 | 22508726 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.85e-03 | 262 | 69 | 4 | 36880596 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.10e-03 | 19 | 47 | 2 | 50 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 1.21e-05 | 199 | 67 | 6 | M3478 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.15e-06 | 29 | 68 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 160 | 69 | 6 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 160 | 69 | 6 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-06 | 173 | 69 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-06 | 181 | 69 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| Disease | Weill-Marchesani syndrome | 2.77e-05 | 4 | 64 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.77e-05 | 4 | 64 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement | 6.91e-05 | 6 | 64 | 2 | EFO_0800394 | |
| Disease | functional impairment measurement | 9.66e-05 | 7 | 64 | 2 | EFO_0005412 | |
| Disease | fatty acid desaturase enzyme activity measurement | 1.29e-04 | 8 | 64 | 2 | EFO_0009791 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 2.06e-04 | 10 | 64 | 2 | EFO_0800464 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.47e-04 | 153 | 64 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 3.56e-04 | 13 | 64 | 2 | OBA_2045082 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 8.58e-04 | 20 | 64 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | saturated fatty acids to total fatty acids percentage | 9.47e-04 | 21 | 64 | 2 | EFO_0022305 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 9.47e-04 | 21 | 64 | 2 | OBA_2045083 | |
| Disease | Vitiligo | 1.39e-03 | 101 | 64 | 3 | EFO_0004208 | |
| Disease | ceramide measurement | 1.71e-03 | 235 | 64 | 4 | EFO_0010222 | |
| Disease | suicidal ideation | 1.81e-03 | 29 | 64 | 2 | EFO_0004320 | |
| Disease | 1,5 anhydroglucitol measurement | 1.81e-03 | 29 | 64 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSEASAEHIEARRRA | 1171 | Q68DQ2 | |
| EEREARFCNTVHDIV | 216 | Q9UKF6 | |
| VATFHDCEDAARELQ | 61 | Q9P2X0 | |
| VTCFSDVIRFDVNTH | 1651 | Q7Z2Y8 | |
| NVDIRAFIESCSHRS | 201 | Q01954 | |
| ALHEACARAQFDCVR | 146 | Q96NS5 | |
| DAAEVEHCLTRRFRD | 46 | A2A2Z9 | |
| EAAARHEEAVGQVCV | 1516 | Q8IYW2 | |
| QEAQDRHTEAVRCAE | 1271 | Q9UPS8 | |
| VRERIFAHDSVCSQE | 291 | Q9UBL0 | |
| PRDSVDFRAAQCAEH | 641 | Q8TE57 | |
| DFRAAQCAEHNSRRF | 646 | Q8TE57 | |
| VDAAVFVTRTDFCVH | 336 | Q8TE56 | |
| DAAEVEHCLTRRFRD | 46 | Q9H560 | |
| TVSRRFAEAACDVVH | 191 | P28907 | |
| LFDHHVQRAVCDTRA | 11 | Q5RL73 | |
| RAHVVRFHECVEETE | 346 | Q13702 | |
| ACEQAEADAVHLARE | 246 | O95755 | |
| CHIFTVSARDADAQE | 471 | Q9Y5I1 | |
| QDIRHEASDFPCRVA | 21 | P18031 | |
| CDASRRIVVADKDNH | 661 | Q2Q1W2 | |
| EESHSRNDCRAVIIF | 176 | P04201 | |
| TGEQRIHAREDACIF | 46 | Q5VT28 | |
| CVAVSEAGEARRHFQ | 3481 | Q8NDA2 | |
| GSREERREAFAAACH | 741 | Q9Y3R5 | |
| FSCLVNGEEREQTHR | 596 | Q13387 | |
| HARDQAREQDRAHAC | 341 | Q13585 | |
| AREQDRAHACPAVEE | 346 | Q13585 | |
| CHTAEARRVDEVFED | 691 | Q63HM2 | |
| RVAEAVAHFEAQRDS | 226 | Q6PJ61 | |
| RDADHFRCSTFAELQ | 831 | Q9ULI4 | |
| AEEAACHSFRAAENR | 501 | A6NI86 | |
| EAACHSFRAAENREL | 531 | H0YKK7 | |
| CHIFTVSARDADAQE | 471 | Q9Y5H7 | |
| VAHRAFENDVDALCN | 256 | P05166 | |
| HFELERSTTCARDFV | 1666 | O60494 | |
| HSLVRQTEECAEGFR | 961 | Q8N0W3 | |
| SHADFRDCRAALAEI | 706 | Q9Y4F1 | |
| FVEACRAREAAFDAE | 181 | Q8N6I1 | |
| CNVARIEAEREAGVH | 1636 | Q14767 | |
| VFARVDCDQHSDIAQ | 86 | Q9BS26 | |
| RVFERVANILHDDCA | 176 | Q9BS26 | |
| NECERHVIFARTDAD | 101 | Q9P2N6 | |
| CRSHNERVVAVADDF | 801 | Q32P44 | |
| VNHVRTRDFDCCLAV | 991 | Q9C0E4 | |
| HECFRVFSDRLVDAA | 2646 | Q9P225 | |
| ASRHACVEVQDEIAF | 636 | P43246 | |
| RAFEHVFESVQCAEN | 116 | Q9P2E2 | |
| AEIVLEAFCAHASQR | 581 | Q96R06 | |
| RCLVENAGDVAFVRH | 561 | P08582 | |
| CIRHSSTFDQTAERD | 201 | O75157 | |
| AFIQHDETRDHVEVC | 261 | Q7L592 | |
| KDAVARCHEAERNIA | 181 | P0DJD1 | |
| EEELCHRREARAFSE | 2626 | Q7Z333 | |
| AEARARFCVSAAHTR | 496 | Q9NUV7 | |
| GLFCRADHDVVERAS | 126 | P61371 | |
| AGHCRIEVSREEIFE | 396 | Q9HCE7 | |
| ELRTHRAFCASNTED | 166 | Q96SE0 | |
| DIDVDRVACFHDAVQ | 1456 | Q63HN8 | |
| HCFENAHRVRVSADT | 756 | O95985 | |
| DACLREAVAHENNRA | 56 | Q99747 | |
| HRNDYVAAERCVRES | 206 | Q99747 | |
| RQRLEHFAANCEEAI | 346 | Q96PX9 | |
| VRVCARHAEAQAAAR | 46 | Q9NZV5 | |
| DHRERLRNSACAVSE | 321 | Q9H1K6 | |
| HLEVCSRDFATEVRA | 81 | O75886 | |
| ASRAHQIFEEFICSE | 111 | O15492 | |
| RNDSCVVHEDFREDI | 206 | Q9P0L9 | |
| CARAHQAHAVVAEEV | 361 | Q9UHR6 | |
| ARAEAEQSVTCAHCR | 706 | O43149 | |
| EHRFFRRSVICDSNA | 76 | Q9H4A3 | |
| QDTVEQLRCEHCARF | 381 | P56192 | |
| EVSHQRCQEREFGLE | 91 | Q9Y473 |